Barclays raised the firm’s price target on Levi Strauss (LEVI) to $24 from $20 and keeps an Overweight rating on the shares. The firm says the company’s fiscal Q2 provided further evidence that the business is on the right trajectory with broad-based growth across geographies.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LEVI:
- Levi Strauss Reports Strong Earnings with Growth Across Key Segments
- Levi Strauss & Co: Strong Market Position and Growth Potential Justify Buy Rating
- Levi Strauss price target raised to $24 from $21 at Telsey Advisory
- Morning Movers: Capricor Therapeutics plunges following CRL from FDA
- Video: Capricor plunges after CRL, Performance Foods up after seeing interest